Shenzhen Chipscreen Biosciences Co.,Ltd. Posted 3.7 Million Yuan Net Loss in First Quarter of 2022

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net loss of 3.7 million yuan in the first quarter of 2022, narrowing 49.2% year-on-year.

Meanwhile, the company posted 104.5 million yuan in revenue, up 38.7% year-on-year.

At the end of the reporting period, it had 2.1 billion yuan in total assets and 644.1 million yuan in total liabilities, with a liability-to-asset ratio of 31.2%.